Media Affairs@FDAMediaSep 25, 2025FDA Authorizes Marketing of First Eyeglass Lenses to Slow Progression of Pediatric Myopia FDA Authorizes Marketing of First Eyeglass Lenses to Slow Progression of Pediatric MyopiaFrom fda.gov6062029091.3K01.3K
Media Affairs@FDAMediaSep 25, 2025FDA Removes Risk Evaluation and Mitigation Strategies (REMS) for Caprelsa (vandetanib) FDA Removes Risk Evaluation and Mitigation Strategies (REMS) for Caprelsa (vandetanib)From fda.gov2021016069880988
Media Affairs@FDAMediaSep 23, 2025FDA Responds to Evidence of Possible Association Between Autism and Acetaminophen Use During Pregnancy FDA Responds to Evidence of Possible Association Between Autism and Acetaminophen Use During...From fda.gov3033033038460846
Media Affairs@FDAMediaSep 23, 2025FDA Takes Action to Make a Treatment Available for Autism Symptoms FDA Takes Action to Make a Treatment Available for Autism SymptomsFrom fda.gov3034046010601
Media Affairs@FDAMediaSep 19, 2025FDA Grants Accelerated Approval to First Treatment for Barth Syndrome FDA Grants Accelerated Approval to First Treatment for Barth SyndromeFrom fda.gov2024044810481
Media Affairs@FDAMediaSep 12, 2025FDA Launches Real-Time Adverse Event Reporting Dashboard for Cosmetic Products bit.ly/3JYtM863032024045940594
Media Affairs@FDAMediaSep 10, 2025HHS, CBP Seize $86.5 Million Worth of Illegal E-Cigarettes in Largest-Ever Operation bit.ly/45YUxBN1012022025460546
Media Affairs@FDAMediaSep 10, 2025FDA Issues New Guidance to Expand Non-Opioid Options for Chronic Pain, Curb Misuse FDA Issues New Guidance to Expand Non-Opioid Options for Chronic Pain, Curb MisuseFrom fda.gov2021011013830383
Media Affairs@FDAMediaSep 9, 2025FDA Launches Crackdown on Deceptive Drug Advertising FDA Launches Crackdown on Deceptive Drug AdvertisingFrom fda.gov1012024042.2K02.2K
Media Affairs@FDAMediaSep 5, 2025FDA Approves Expanded Use of Vonvendi for von Willebrand Disease, Including for Certain Uses for Children FDA Approves Expanded Use of Vonvendi for von Willebrand Disease, Including for Certain Uses for...From fda.gov1013390339
Media Affairs@FDAMediaSep 5, 2025FDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients FDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug IngredientsFrom fda.gov1011013420342
Media Affairs@FDAMediaSep 4, 2025FDA Announces Real-Time Release of Complete Response Letters, Posts Previously Unpublished Batch of 89 FDA Announces Real-Time Release of Complete Response Letters, Posts Previously Unpublished Batch of...From fda.gov1012700270
Media Affairs@FDAMediaSep 3, 2025FDA Advances Rare Disease Drug Development with New Evidence Principles bit.ly/4lYA0C71011012920292
Media Affairs@FDAMediaSep 2, 2025FDA Urges Nicotine Pouch Manufacturers To Use Child-Resistant Packaging Following Increasing Reports of Accidental Exposure FDA Urges Nicotine Pouch Manufacturers To Use Child-Resistant Packaging Following Increasing...From fda.gov1012023570357
